Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Editorial
The Role of Pharmaceutical Companies in Research and Development — Plaudits and Cautions
Quentin Rae-Grant
(PDF)

Guest Editorial
Diagnostic Concepts and the Prevention of Schizophrenia
Ming T Tsuang, Stephen V Faraone
(PDF)

In Review
Understanding Predisposition to Schizophrenia: Toward Intervention and Prevention
Ming T Tsuang, William S Stone, Stephen V Faraone
(PDF)

Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues
Stephen V Faraone, Hendricks Brown, Stephen J Glatt, Ming T Tsuang

(PDF)

Original Research
Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction

Ôenel Tot, Aynur Özge, Ülkü Çömelekolu, Kemal Yazici, Nilgün Bal

(PDF)

Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study
Samantha R Gross, Sean P Barrett, John S Shestowsky, Robert O Pihl

(PDF)

Research Methods in Psychiatry
The 2 “Es” of Research: Efficacy and Effectiveness Trials

David L Streiner,

(PDF)

Brief Communication
Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients

Helmut Peter, Iver Hand, Fritz Hohagen, Anne Koenig, Olaf Mindermann, Frank Oeder, Markus Wittich

(PDF)

Perceptions of Intimidation in the Psychiatric Educational Environment in Edmonton, Alberta
Phil Tibbo, CJ de Gara, Treena M Blake, Carolyn Steinberg, Brian Stonehocker

(PDF)

Senior Residents in Psychiatry: Views on Training in Developmental Disabilities
Philip Burge, Hélène Ouellette-Kuntz, Bruce McCreary, Elspeth Bradley, Pierre Leichner

(PDF)

Evidence That Latitude is Directly Related to Variation in Suicide Rates
George E Davis, Walter E Lowell

(PDF)

CPA Position Paper
The 1996 CMA Code of Ethics Annotated for Psychiatrists

 


Book Reviews
(PDF)
Substance Abuse Treatment and the Stages of Change: Selecting and Planning Interventions.

Handbook of Personality Disorders: Theory, Research and Treatment

A Clinical Guide to Sleep Disorders in Children and Adolescents

Love Relations: Normality and Pathology

The Mental Health Matrix: A Manual to Improve Services


Letters to the Editor
(PDF)
Massive Weight Gain and Hostility Force Mirtazapine Stoppage

Functional Dyspepsia and Mirtazapine

Re: Using Language in Psychiatry

Dr Fine Replies

Psychotic Mania in Bipolar II Depression Related to Sertraline Discontinuation

Délirium associé à l’azithromycine

Behavioural Therapy for the Treatment of Alcohol Abuse and Dependence

Original Research

Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction

Ôenel Tot, MD1, Aynur Özge, MD2, Ülkü Çömelekolu, PhD3, Kemal Yazici, MD4, Nilgün Bal, MD5

 

Objective: Our objectives were 1) to determine hemispheric asymmetry and regional differences on the EEGs of patients with obsessive–compulsive disorder (OCD); and 2) to investigate the effects of sex, treatment response, illness duration, and Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores on quantitative electroencephalographic (QEEG) measurements.

Method: We recorded EEGs (12-channel) from 22 unmedicated patients with OCD but no depression and from 20 age- and sex-matched control subjects. All patients and control subjects underwent detailed neurological and psychiatric evaluations including the Hamilton Depression Rating Scale (HDRS) and Y-BOCS.

Results: QEEG revealed higher frequencies of slow-wave bands and lower frequencies of alpha activity at predominantly left frontotemporal localization in patients with OCD, compared with control subjects. Analysis of variance of QEEG parameters and clinical characteristics showed that sex had a significant effect on delta and alpha frequencies of frontotemporal areas during hyperventilation (HV). Increasing total Y-BOCS score correlated positively with increased frequencies of right parietal delta activity and decreased frequencies of right frontotemporal alpha activity during HV. A significantly increased left frontal slow-wave activity and decreased beta activity during HV in treatment responders led us to consider that frontal lobe functions were better in this group of patients. Illness duration had no important effect on QEEG.

Conclusion: Patients with OCD showed important frontotemporal dysfunction, predominantly in the left hemisphere. This was particularly evident in female subjects and in treatment responders. QEEG may be beneficial in understanding the neurobiological basis of OCD.

(Can J Psychiatry 2002;47:538–545)

Click here for Author Affiliations

Clinical Implications

  • The finding of left frontotemporal dysfunction observed in visual EEG in patients with obsessive– compulsive disorder (OCD) has been confirmed by quantitative electroencephalographic (QEEG) measurements.

  • Left frontotemporal dysfunction was most significant in female patients with OCD and in treatment responders.

  • The severity of left frontotemporal dysfunction correlated positively with the severity of OCD.

Limitations

  • Because specific software was lacking, we performed QEEG analysis by transferring the data obtained from the EEG equipment software to a statistical computer program, and this method may have caused some errors.

  • A second QEEG analysis was not performed at the end of the treatment period.

  • A single activation method (hyperventilation) was used in EEG.

  • The number of male patients was relatively low.

Key Words: obsessive-compulsive disorder, electroencephalogram, EEG, quantitative analysis, hemispheric asymmetry, left hemisphere, frontotemporal dysfunction

Résumé : Association des résultats des mesures EEGQ avec les caractéristiques cliniques du trouble obsessionnel-compulsif : preuve de la dysfonction frontotemporale gauche

Obsessive–compulsive disorder (OCD) is characterized by recurrent and disturbing thoughts (obsessions) or repetitive and stereotyped behaviours (compulsions), or both, that the sufferer feels driven to perform but recognizes as irrational or excessive (1,2). Over the past decade, there has been increasing interest in the neurobiological basis of OCD. Neuroimaging and positron emission tomography (PET) studies indicate an increased prevalence of neurological soft signs and increased metabolism in the frontal cortex, basal ganglia, and cingulate gyrus (3–9).

There are relatively few studies investigating the EEG manifestations of the obsessional syndrome. In the first such study, Pacella and others found that 64% of 31 patients had definite EEG abnormalities, principally in the slow-wave frequencies (10). This was confirmed by Rockwell and Simons, who obtained EEG abnormalities in the same frequency bands in 54% of 24 patients (11). Epstein and Bailine described the appearance of temporal spikes during stage I and the REM phase of sleep in 3 patients with obsessional symptoms and abnormal waking EEG, but without epilepsy (12).

Flor-Henry and others reported relatively decreased variability in the left temporal region (3). Insel and others reported that, in subjects found to have abnormal EEGs, the abnormality was “nonspecific theta activity” (13). In reviewing EEG data obtained from patients with OCD, Jenike and Brotman concluded that EEG disturbances, when present, were predominantly in the temporal and frontotemporal regions (14).

In a detailed quantitative electroencephalographic (QEEG) study, Khanna found decreased power in the nondominant frontotemporal and posterior temporal regions (15). In an important study using QEEG and brain mapping, Perros and others found significantly increased relative power in the theta-2 band in the left temporal and central regions and significantly reduced variability in frontal and temporal regions (16).

Prichep and others reported the existence of 2 subtypes of OCD patients within a clinically homogeneous group of patients who met DSM-III-R criteria for OCD. Their QEEG results suggested that Cluster 1 (treatment nonresponders) was characterized by excess relative power in theta, especially in the frontal and frontotemporal regions, and Cluster 2 (treatment responders) was characterized by increased relative power in alpha (9).

Drake and others compared EEG spectral measures in patients with OCD and in healthy control subjects and reported that modal alpha frequency (MAF) and maximal alpha frequency (MxAF) were reduced in the frontal regions in patients, compared with control subjects (17). Most of these observations support the hypothesis that obsessions and compulsions have a physiologic basis and frontal lobe disturbance in their pathophysiology. However, studies conducted so far have described EEG changes obtained from restricted region recordings. The association of EEG findings with the clinical characteristics of OCD and with patients’ sex has not been clarified.

This study investigates EEG changes at resting state (RS) and during hyperventilation (HV) in unmedicated OCD patients without depression and in healthy control subjects. It also investigates the possible association of clinical characteristics of OCD and QEEG findings.


Method

Subjects

The patients and the control subjects were matched for age and sex. Table 1 gives their demographic characteristics. We selected 22 right-handed OCD patients as the study group and 20 right-handed healthy subjects as the control group. Patients were consecutively selected from among those applying to the psychiatric outpatient clinic of Mersin University Faculty of Medicine. Twelve patients had never taken treatment for OCD. Ten patients had previous treatment periods but had not taken psychotropic drugs for at least 2 weeks prior to the study, either from noncompliance or because of adverse effects. None of the control subjects had a history of any psychiatric disorder, and none had ever taken drugs affecting the central nervous system (CNS). Inclusion criteria for the study were as follows: 1) a strict DSM-IV diagnosis of OCD, 2) the presence of symptoms for at least 1 year, 3) being free of psychotropic drugs for at least 2 weeks prior to the study, 4) being neurologically intact (that is, without epilepsy, stroke, head injury, dementia, or sleep disorder), 5) being free of concomitant severe or chronic medical illnesses (for example, hepatic failure or chronic renal failure) or comorbid psychiatric disorders (for example, other anxiety disorders, depression, schizophrenia, or substance abuse), and 6) having no history of psychosurgery or any other neurosurgical procedure. All patients received treatment for OCD. Depressive symptoms on the Hamilton Depression Rating Scale (HDRS) were absent or mild (that is, scores were below 15) (18). Validity and reliability of the Turkish version of the HDRS has been tested by Akdemir and others (19). Patients reported a wide range of obsessions and compulsions. Most often, these included hand-washing, checking, and hoarding compulsions and contamination, aggressive, somatic, and religious obsessions, as well as pathological doubt. Eight patients showed obsessional thoughts without significant compulsions. We administered the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to assess the severity of obsessive–compulsive symptoms (20,21). Validity and reliability of the Turkish version of Y-BOCS has been tested by Tek and others (22).

After clinical evaluation, patients were started on pharmacotherapy (11 patients on fluvoxamine [dosage range, 100 to 300 mg daily], 4 on fluoxetine [dosage range, 20 to 80 mg daily], and 5 on sertraline [dosage range, 100 to 200 mg daily]). Treatment drugs were determined on the basis of previous treatment and adverse effects. Dosages were adjusted according to each patient’s clinical condition and adverse-effect status. At the end of month 3, we evaluated treatment response, using the Clinical Global Impression Scale (CGI) (23). Responders were defined as very much improved or much improved, and nonresponders as those who showed minimal or no change on CGI; 13 patients were responders and 7 patients were nonresponders. Two patients discontinued drug therapy and were excluded from the treatment-response analysis.

All subjects gave informed consent after a full explanation of the study and the EEG testing procedure.

1 | 2 | 3 | 4


CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2001 | Index RCP des auteurs 2001
Subject Index to 2001 | Index RCP des sujets 2001
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil